{
    "code": "60001037",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001037",
    "time": "2020-04-24 03:20:57",
    "許可證字號": "衛部菌疫輸字第001037號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/02\/09",
    "發證日期": "106\/02\/09",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000103707",
    "中文品名": "保脂通注射劑75毫克",
    "英文品名": "Praluent solution for injection 75mg",
    "適應症": "1.\t預防心血管事件：對於已確診心血管疾病的成年病人，Praluent可用於降低心肌梗塞、中風以及需住院治療的不穩定心絞痛之風險。\r\n2.\t原發性高血脂症(包含異合子家族性高膽固醇血症)：Praluent可單獨使用或併用其他降血脂藥物(例如：statin類藥物、ezetimibe)，作為飲食外的輔助治療以降低原發性高血脂症成年病人之低密度脂蛋白膽固醇(LDL-C)。",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 1ml預填針筒 1ml注射筆",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "111\/02\/09",
    "主成分略述": "Alirocumab",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "1707201200  賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "MFR0940000  Sanofi Winthrop Industrie",
            "製造廠廠址": "1051 BOULEVARD INDUSTRIEL, 76580 LE TRAIT, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "成品及包裝廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "7770824858  台灣大昌華嘉股份有限公司",
            "製造廠廠址": "桃園市楊梅區梅獅路二段629號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FDE0273000  SANOFI-AVENTIS DEUTSCHLAND GMBH",
            "製造廠廠址": "BRUNINGSTRASSE 50,D-65926 FRANKFURT AM (MAIN) GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FIE0035000  GENZYME IRELAND LIMITED",
            "製造廠廠址": "IDA INDUSTRIAL PARK, OLD KILMEADEN ROAD, WATERFORD, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FUS0332000  REGENERON PHARMACEUTICALS INC.",
            "製造廠廠址": "81 COLUMBIA TURNPIKE RENSSELAER NY 12144 U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "30021500005 免疫產品，具有劑量或零售包裝式樣者Immunological products, put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2406004600",
            "成分名稱": "Alirocumab",
            "含量描述": "",
            "含量": "75.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "20190320保脂通注射劑75毫克_仿單核定本-109-03-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=007&Type=9"
        },
        {
            "title": "Praluent 75mg pen中文使用手冊-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=003&Type=9"
        },
        {
            "title": "Praluent 75mg syringe中文使用手冊-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=002&Type=9"
        },
        {
            "title": "pen 外盒 一隻裝 75mg-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=005&Type=8"
        },
        {
            "title": "pen 標籤 75mg-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=004&Type=8"
        },
        {
            "title": "syringe 外盒 一隻裝 75mg-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=003&Type=8"
        },
        {
            "title": "syringe 標籤 75mg-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=002&Type=8"
        },
        {
            "title": "中文標籤-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=001&Type=8"
        }
    ]
}